Tiago Fauth

Stock Analyst at Wells Fargo

(0)
# 4860
Out of 5,291 analysts
163
Total ratings
26.36%
Success rate
-27.47%
Average return
44 Stocks
Name Action Price Target Current % Upside Ratings Updated
Tectonic Therapeutic
Maintains: Overweight
112 101
18.63 442.14% 4 Mar 21, 2025
Alnylam Pharmaceutic...
Maintains: Equal-Weight
275 287
268.5 6.89% 5 Mar 21, 2025
Pliant Therapeutics
Maintains: Equal-Weight
4 3
1.47 104.08% 2 Mar 4, 2025
Verona Pharma
Maintains: Overweight
74 93
62.69 48.35% 4 Feb 28, 2025
Keros Therapeutics
Maintains: Overweight
28 26
10.79 140.96% 6 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
18 17
8.41 102.14% 1 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
85 107
77.89 37.37% 3 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 11
0.93 1082.8% 2 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
75 88
37.8 132.8% 7 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
8
2.91 174.91% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
5.04 78.57% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
56 68
54.18 25.51% 1 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 22
8.63 154.92% 2 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
75
52.37 43.21% 1 Aug 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
350 380
306.88 23.83% 4 Aug 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
35 2
2.51 -20.32% 2 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
63 62
1.22 4981.97% 5 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
89
154.59 -42.43% 16 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
51
14.47 252.45% 3 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
120
71.4 68.07% 7 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
120
0.6 19900% 6 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
4
18.36 -78.21% 4 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
22 17
n/a n/a 2 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14
2.71 416.61% 4 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
4
0.3 1233.33% 5 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
26
7.05 268.79% 5 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 28
2.31 1112.12% 7 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
70 81
24.28 233.61% 11 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
139 200
n/a n/a 5 Apr 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
1
n/a n/a 3 Apr 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
8
0.38 2005.26% 5 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14
1.06 1220.75% 2 Mar 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
38 34
0.66 5051.52% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
150
3.41 4298.83% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
29
36.7 -20.98% 1 Jan 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
13
2.42 437.19% 1 Dec 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 13
1.25 940% 2 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20
n/a n/a 3 Sep 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
3 2
1.15 73.91% 4 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
297 340
588.92 -42.27% 3 Dec 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 18
n/a n/a 2 Sep 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
102 98
n/a n/a 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
265 259
306.93 -15.62% 1 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
60 42
n/a n/a 5 Nov 10, 2020